NCT05016050: A trial that was reported late by Happify Inc.
This trial has reported, although it was 251 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05016050 |
|---|---|
| Title | A Real-World Evidence, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of HPDT-DA-013 Digital Therapeutic in the Treatment of Major Depressive Disorder(MDD)and Generalized Anxiety Disorder(GAD) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 9, 2021 |
| Completion date | March 16, 2023 |
| Required reporting date | March 15, 2024, midnight |
| Actual reporting date | Nov. 22, 2024 |
| Date last checked at ClinicalTrials.gov | Jan. 15, 2026 |
| Days late | 251 |